Nathaniel J. Hogrebe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nathaniel J. Hogrebe has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Jeffrey R. Millman
Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, USA
8 shared publications - Punn Augsornworawat
Department of Immunology Faculty of Medicine Siriraj Hospital Mahidol University, Bangkok, Thailand
7 shared publications Leonardo Velazco-Cruz
Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, MSC 8127-057-08, St. Louis, USA
4 shared publications- Keith J. Gooch
Department of Biomedical Engineering, The Ohio State University, Columbus, OH 43210, USA
3 shared publications - Kristina G. Maxwell
Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, USA
3 shared publications - Mason D. Schmidt
Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, MSC 8127-057-08, St. Louis, USA
3 shared publications
Latest Publications
- Open Access
- 2 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Depolymerizing F-actin accelerates the exit from pluripotency to enhance stem cell-derived islet differentiation
In this study, we demonstrate that cytoskeletal state at the onset of directed differentiation impacts the exit of human pluripotent stem cells (hPSCs) from pluripotency and downstream lineage specification. In particular, depolymerizing F-actin with latrunculin A (latA) during the first 24 h of definitive endoderm formation facilitates efficient loss of pluripotency and alters Activin/Nodal, BMP, c-Jun, and WNT signaling dynamics. These signaling changes influence downstream patterning of the gut tube, leading to improved pancreatic progenitor identity and decreased expression of markers associated with other endodermal lineages. Continued differentiation generates islets containing a higher percentage of β cells that exhibit improved maturation, insulin secretion, and ability to reverse hyperglycemia. Furthermore, this latA treatment reduces enterochromaffin cells in the final cell population and corrects differentiations from hPSC lines that otherwise fail to consistently produce pancreatic islets, highlighting the importance of cytoskeletal signaling at the onset of directed differentiation.
- 2 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessDepolymerizing F-actin accelerates the exit from pluripotency to enhance stem cell-derived islet differentiation
In this study, we demonstrate that cytoskeletal state at the onset of directed differentiation impacts the exit of human pluripotent stem cells (hPSCs) from pluripotency and downstream lineage specification. In particular, depolymerizing F-actin with latrunculin A (latA) during the first 24 h of definitive endoderm formation facilitates efficient loss of pluripotency and alters Activin/Nodal, BMP, c-Jun, and WNT signaling dynamics. These signaling changes influence downstream patterning of the gut tube, leading to improved pancreatic progenitor identity and decreased expression of markers associated with other endodermal lineages. Continued differentiation generates islets containing a higher percentage of β cells that exhibit improved maturation, insulin secretion, and ability to reverse hyperglycemia. Furthermore, this latA treatment reduces enterochromaffin cells in the final cell population and corrects differentiations from hPSC lines that otherwise fail to consistently produce pancreatic islets, highlighting the importance of cytoskeletal signaling at the onset of directed differentiation.
- 21 May 2025
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 122 (8) , 2206-2217
Controlling Human Stem Cell‐Derived Islet Composition Using Magnetic Sorting
Stem cell‐derived islets (SC‐islets) consist of multiple hormone‐producing cell types and offer a promising therapeutic avenue for treating type 1 diabetes (T1D). Currently, the composition of cell types generated within these SC‐islets cannot be controlled via soluble factors during this differentiation process and consist of off‐target cell types. In this study, we devised a magnetic‐activated cell sorting protocol to enrich SC‐islets for CD49a, a marker associated with functional insulin‐producing β cells. SC‐islets were generated from human pluripotent stem cells using an adherent differentiation protocol and then sorted and aggregated into islet‐like clusters to produce CD49a‐enriched, CD49a‐depleted, and unsorted SC‐islets. Single‐cell RNA sequencing (scRNA‐seq) and immunostaining revealed that CD49a‐enriched SC‐islets had higher proportions of β cells and improved transcriptional identity compared to other cell types. Functional assays demonstrated that CD49a‐enriched SC‐islets exhibited enhanced glucose‐stimulated insulin secretion both In vitro and In Vivo following transplantation into diabetic mice. These findings suggest that CD49a‐based sorting significantly improves β cell identity and the overall function of SC‐islets, improving their effectiveness for T1D cell replacement therapies.
- 21 May 2025
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 122 (8) , 2206-2217
Controlling Human Stem Cell‐Derived Islet Composition Using Magnetic Sorting
Stem cell‐derived islets (SC‐islets) consist of multiple hormone‐producing cell types and offer a promising therapeutic avenue for treating type 1 diabetes (T1D). Currently, the composition of cell types generated within these SC‐islets cannot be controlled via soluble factors during this differentiation process and consist of off‐target cell types. In this study, we devised a magnetic‐activated cell sorting protocol to enrich SC‐islets for CD49a, a marker associated with functional insulin‐producing β cells. SC‐islets were generated from human pluripotent stem cells using an adherent differentiation protocol and then sorted and aggregated into islet‐like clusters to produce CD49a‐enriched, CD49a‐depleted, and unsorted SC‐islets. Single‐cell RNA sequencing (scRNA‐seq) and immunostaining revealed that CD49a‐enriched SC‐islets had higher proportions of β cells and improved transcriptional identity compared to other cell types. Functional assays demonstrated that CD49a‐enriched SC‐islets exhibited enhanced glucose‐stimulated insulin secretion both In vitro and In Vivo following transplantation into diabetic mice. These findings suggest that CD49a‐based sorting significantly improves β cell identity and the overall function of SC‐islets, improving their effectiveness for T1D cell replacement therapies.
- Open Access
- 9 August 2023
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (10) , 1546
Author Correction: Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification
- 9 August 2023
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (10) , 1546
Open AccessAuthor Correction: Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification
- Open Access
- 15 May 2023
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (6) , 904-916
Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification
Insulin-producing β cells created from human pluripotent stem cells have potential as a therapy for insulin-dependent diabetes, but human pluripotent stem cell-derived islets (SC-islets) still differ from their in vivo counterparts. To better understand the state of cell types within SC-islets and identify lineage specification deficiencies, we used single-nucleus multi-omic sequencing to analyse chromatin accessibility and transcriptional profiles of SC-islets and primary human islets. Here we provide an analysis that enabled the derivation of gene lists and activity for identifying each SC-islet cell type compared with primary islets. Within SC-islets, we found that the difference between β cells and awry enterochromaffin-like cells is a gradient of cell states rather than a stark difference in identity. Furthermore, transplantation of SC-islets in vivo improved cellular identities overtime, while long-term in vitro culture did not. Collectively, our results highlight the importance of chromatin and transcriptional landscapes during islet cell specification and maturation.
- 15 May 2023
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (6) , 904-916
Open AccessSingle-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification
Insulin-producing β cells created from human pluripotent stem cells have potential as a therapy for insulin-dependent diabetes, but human pluripotent stem cell-derived islets (SC-islets) still differ from their in vivo counterparts. To better understand the state of cell types within SC-islets and identify lineage specification deficiencies, we used single-nucleus multi-omic sequencing to analyse chromatin accessibility and transcriptional profiles of SC-islets and primary human islets. Here we provide an analysis that enabled the derivation of gene lists and activity for identifying each SC-islet cell type compared with primary islets. Within SC-islets, we found that the difference between β cells and awry enterochromaffin-like cells is a gradient of cell states rather than a stark difference in identity. Furthermore, transplantation of SC-islets in vivo improved cellular identities overtime, while long-term in vitro culture did not. Collectively, our results highlight the importance of chromatin and transcriptional landscapes during islet cell specification and maturation.
- Top Cited Papers
- 4 August 2021
- Published by Springer Nature in Nature Protocols
- Vol. 16 (9) , 4109-4143
Generation of insulin-producing pancreatic β cells from multiple human stem cell lines
We detail a six-stage planar differentiation methodology for generating human pluripotent stem cell–derived pancreatic β cells (SC-β cells) that secrete high amounts of insulin in response to glucose stimulation. This protocol first induces definitive endoderm by treatment with Activin A and CHIR99021, then generates PDX1+/NKX6-1+ pancreatic progenitors through the timed application of keratinocyte growth factor, SANT1, TPPB, LDN193189 and retinoic acid. Endocrine induction and subsequent SC-β-cell specification is achieved with a cocktail consisting of the cytoskeletal depolymerizing compound latrunculin A combined with XXI, T3, ALK5 inhibitor II, SANT1 and retinoic acid. The resulting SC-β cells and other endocrine cell types can then be aggregated into islet-like clusters for analysis and transplantation. This differentiation methodology takes ~34 d to generate functional SC-β cells, plus an additional 1–2 weeks for initial stem cell expansion and final cell assessment. This protocol builds upon a large body of previous work for generating β-like cells. In this iteration, we have eliminated the need for 3D culture during endocrine induction, allowing for the generation of highly functional SC-β cells to be done entirely on tissue culture polystyrene. This change simplifies the differentiation methodology, requiring only basic stem cell culture experience as well as familiarity with assessment techniques common in biology laboratories. In addition to expanding protocol accessibility and simplifying SC-β-cell generation, we demonstrate that this planar methodology is amenable for differentiating SC-β cells from a wide variety of cell lines from various sources, broadening its applicability.
- 4 August 2021
- Published by Springer Nature in Nature Protocols
- Vol. 16 (9) , 4109-4143
Top Cited PapersGeneration of insulin-producing pancreatic β cells from multiple human stem cell lines
We detail a six-stage planar differentiation methodology for generating human pluripotent stem cell–derived pancreatic β cells (SC-β cells) that secrete high amounts of insulin in response to glucose stimulation. This protocol first induces definitive endoderm by treatment with Activin A and CHIR99021, then generates PDX1+/NKX6-1+ pancreatic progenitors through the timed application of keratinocyte growth factor, SANT1, TPPB, LDN193189 and retinoic acid. Endocrine induction and subsequent SC-β-cell specification is achieved with a cocktail consisting of the cytoskeletal depolymerizing compound latrunculin A combined with XXI, T3, ALK5 inhibitor II, SANT1 and retinoic acid. The resulting SC-β cells and other endocrine cell types can then be aggregated into islet-like clusters for analysis and transplantation. This differentiation methodology takes ~34 d to generate functional SC-β cells, plus an additional 1–2 weeks for initial stem cell expansion and final cell assessment. This protocol builds upon a large body of previous work for generating β-like cells. In this iteration, we have eliminated the need for 3D culture during endocrine induction, allowing for the generation of highly functional SC-β cells to be done entirely on tissue culture polystyrene. This change simplifies the differentiation methodology, requiring only basic stem cell culture experience as well as familiarity with assessment techniques common in biology laboratories. In addition to expanding protocol accessibility and simplifying SC-β-cell generation, we demonstrate that this planar methodology is amenable for differentiating SC-β cells from a wide variety of cell lines from various sources, broadening its applicability.
- 22 April 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (540)
Gene-edited human stem cell–derived β cells from a patient with monogenic diabetes reverse preexisting diabetes in mice
Patient stem cell–derived β cells corrected for a diabetes-causing variant in WFS1 restore glucose homeostasis when transplanted into diabetic mice.
- 22 April 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (540)
Gene-edited human stem cell–derived β cells from a patient with monogenic diabetes reverse preexisting diabetes in mice
Patient stem cell–derived β cells corrected for a diabetes-causing variant in WFS1 restore glucose homeostasis when transplanted into diabetic mice.
- Top Cited PapersOpen Access
- 24 February 2020
- Published by Springer Nature in Nature Biotechnology
- Vol. 38 (4) , 460-470
Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells
Generation of pancreatic β cells from human pluripotent stem cells (hPSCs) holds promise as a cell replacement therapy for diabetes. In this study, we establish a link between the state of the actin cytoskeleton and the expression of pancreatic transcription factors that drive pancreatic lineage specification. Bulk and single-cell RNA sequencing demonstrated that different degrees of actin polymerization biased cells toward various endodermal lineages and that conditions favoring a polymerized cytoskeleton strongly inhibited neurogenin 3-induced endocrine differentiation. Using latrunculin A to depolymerize the cytoskeleton during endocrine induction, we developed a two-dimensional differentiation protocol for generating human pluripotent stem-cell-derived β (SC-β) cells with improved in vitro and in vivo function. SC-β cells differentiated from four hPSC lines exhibited first- and second-phase dynamic glucose-stimulated insulin secretion. Transplantation of islet-sized aggregates of these cells rapidly reversed severe preexisting diabetes in mice at a rate close to that of human islets and maintained normoglycemia for at least 9 months.
- 24 February 2020
- Published by Springer Nature in Nature Biotechnology
- Vol. 38 (4) , 460-470
Top Cited PapersOpen AccessTargeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells
Generation of pancreatic β cells from human pluripotent stem cells (hPSCs) holds promise as a cell replacement therapy for diabetes. In this study, we establish a link between the state of the actin cytoskeleton and the expression of pancreatic transcription factors that drive pancreatic lineage specification. Bulk and single-cell RNA sequencing demonstrated that different degrees of actin polymerization biased cells toward various endodermal lineages and that conditions favoring a polymerized cytoskeleton strongly inhibited neurogenin 3-induced endocrine differentiation. Using latrunculin A to depolymerize the cytoskeleton during endocrine induction, we developed a two-dimensional differentiation protocol for generating human pluripotent stem-cell-derived β (SC-β) cells with improved in vitro and in vivo function. SC-β cells differentiated from four hPSC lines exhibited first- and second-phase dynamic glucose-stimulated insulin secretion. Transplantation of islet-sized aggregates of these cells rapidly reversed severe preexisting diabetes in mice at a rate close to that of human islets and maintained normoglycemia for at least 9 months.
- Top Cited PapersOpen Access
- 1 February 2019
- Published by Elsevier in Stem Cell Reports
- Vol. 12 (2) , 351-365
Acquisition of Dynamic Function in Human Stem Cell-Derived β Cells
- 1 February 2019
- Published by Elsevier in Stem Cell Reports
- Vol. 12 (2) , 351-365
Top Cited PapersOpen AccessAcquisition of Dynamic Function in Human Stem Cell-Derived β Cells
- 1 April 2018
- Published by Elsevier in Acta Biomaterialia
- Vol. 70, 110-119
Independent control of matrix adhesiveness and stiffness within a 3D self-assembling peptide hydrogel
- 1 April 2018
- Published by Elsevier in Acta Biomaterialia
- Vol. 70, 110-119
Independent control of matrix adhesiveness and stiffness within a 3D self-assembling peptide hydrogel